Aquavit Pharmaceuticals Appoints David J. Goldberg as CMO; Launching AQUAGOLD® at AADNew York City, NEW YORK, March 5, 2014 Aquavit Pharmaceuticals, Inc., a private high-tech life science company, announced today the appoi...
AQUAGOLD® fine touch™ showcased at 2014 South Beach Symposium Miami Beach, Florida, February 17, 2014 AQUAGOLD® fine touch™ was presented at the 2014 South Beach Symposium in Miami during a session o...
AQUAGOLD® fine touch™ Presented at the 2014 IMCAS by Dr. David GoldbergParis, France, February 5, 2014 AQUAGOLD® fine touch™ was featured at the 2014 International Master Course on Aging Skin Conference (IMCA...
AQUAGOLD® fine touch™ featured at Winter Clinical Dermatology Meeting Kohala Coast, HAWAII, January 19, 2014 AQUAGOLD® fine touch™ was featured at the 2014 Winter Clinical Dermatology Conference in Hawaii du...
Aquavit Pharmaceuticals Adds New Advanced Drug Delivery Technology to Product Portfolio NEW YORK, Nov. 5, 2013 Aquavit Pharmaceuticals, Inc. has further extended its personalized drug delivery platform by signing a binding pr...
Aquavit Appoints David Shafer, MD., FACS., New Chief Medical Technology Officer NEW YORK, March 4, 2013 Aquavit Pharmaceuticals Inc. has announced its newest addition to its management team, Dr. David Shafer . He has ...
Dr. B.G. Rhee Joins Aquavit’s Advisory Board SEOUL & NEW YORK, January 21, 2013 We are pleased to announce that Dr. B.G. Rhee has signed on as a member of Aquavit Pharmaceutical’s Ad...
Aquavit Pharmaceuticals Selects Uniquest for New High-Tech Medical Device Manufacturing NEW YORK, December 12, 2012 Aquavit Pharmaceuticals, a privately held specialty pharmaceuticals and medical device company, has signed a ...
Aquavit Pharmaceuticals and Uniquest sign MOU for Alliance Partnership SEOUL & NEW YORK, October 8, 2012 Aquavit Life Sciences, Inc, a wholly owned subsidiary of Aquavit Pharmaceuticals, Inc, announces togeth...
Aquavit Pharmaceuticals forms Alliance Partnership with Accelrys NEW YORK Sept. 21, 2012/PRNewswire/ — Aquavit Pharmaceuticals, Inc. and Accelrys Software Inc. (NASDAQ: ACCL), a leader in scientific inn...
Aquavit and Green Cross sign Strategic Collaboration MOU on IBX-001 Product Development in AsiaSEOUL & NEW YORK, August 8, 2012 Aquavit Pharmaceuticals, Inc. and Green Cross Corp. (006280:Korea SE), a leading biotechnology company i...
Video Interview with Dr. Steven Fagien NEW YORK, April 11, 2012 In a featured web article for the University of Florida, Dr. Steven Fagien was put under the Alumni Spotlight. O...
Dr. Steven Fagien appointed as Chairman, Scientific Advisory Board NEW YORK, February 1, 2012 Steve Fagien MD has joined us as Aquavit as chairman of the Scientific Advisory Board. As a world-class plasti...
IMCAS Paris 2012 PARIS, FRANCE, January 30, 2012 Aquavit Pharmaceuticals, Inc. made its debut at IMCAS Paris on January 27, 2012. The company received a w...
Aquavit Pharmaceuticals Implements First-of-Kind Accelerate-to-Market Strategy NEW YORK, September 2, 2011 Sobin Chang, CEO joined MBA students and faculty members at HAAS Business School, University of California at...
